NO975140L - Transdermalt terapeutisk system (TTS) for administrasjon av testosteron - Google Patents
Transdermalt terapeutisk system (TTS) for administrasjon av testosteronInfo
- Publication number
- NO975140L NO975140L NO975140A NO975140A NO975140L NO 975140 L NO975140 L NO 975140L NO 975140 A NO975140 A NO 975140A NO 975140 A NO975140 A NO 975140A NO 975140 L NO975140 L NO 975140L
- Authority
- NO
- Norway
- Prior art keywords
- testosterone
- tts
- therapeutic system
- administration
- transdermal therapeutic
- Prior art date
Links
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 title abstract 4
- 229960003604 testosterone Drugs 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Nanotechnology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19517145A DE19517145C2 (de) | 1995-05-10 | 1995-05-10 | Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron |
| PCT/EP1996/002013 WO1996035427A1 (de) | 1995-05-10 | 1996-05-10 | Transdermales therapeutisches system (tts) zur verabreichung von testosteron |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO975140D0 NO975140D0 (no) | 1997-11-07 |
| NO975140L true NO975140L (no) | 1997-11-10 |
Family
ID=7761562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO975140A NO975140L (no) | 1995-05-10 | 1997-11-07 | Transdermalt terapeutisk system (TTS) for administrasjon av testosteron |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0825865B1 (cs) |
| JP (1) | JPH11504643A (cs) |
| CN (1) | CN1183723A (cs) |
| AT (1) | ATE208200T1 (cs) |
| AU (1) | AU702710B2 (cs) |
| BR (1) | BR9608255A (cs) |
| CA (1) | CA2220358A1 (cs) |
| CZ (1) | CZ287678B6 (cs) |
| DE (2) | DE19517145C2 (cs) |
| DK (1) | DK0825865T3 (cs) |
| HU (1) | HUP9801130A3 (cs) |
| NO (1) | NO975140L (cs) |
| NZ (1) | NZ308516A (cs) |
| PL (1) | PL323145A1 (cs) |
| SK (1) | SK149797A3 (cs) |
| WO (1) | WO1996035427A1 (cs) |
| ZA (1) | ZA963743B (cs) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1429697A (en) * | 1995-12-29 | 1997-07-28 | Cygnus, Inc. | Systems and methods for the transdermal administration of androgenic agents |
| CA2259407C (en) * | 1996-07-03 | 2006-04-04 | Alza Corporation | Drug delivery devices and process of manufacture |
| US6007837A (en) * | 1996-07-03 | 1999-12-28 | Alza Corporation | Drug delivery devices and process of manufacture |
| DE19646050A1 (de) * | 1996-11-08 | 1998-05-14 | Labtec Gmbh | Transdermales System mit einem speziellen Süßstoff zur Erhöhung der transdermalen Bioverfügbarkeit |
| US6174545B1 (en) | 1997-07-01 | 2001-01-16 | Alza Corporation | Drug delivery devices and process of manufacture |
| EP1079815B1 (de) * | 1998-05-22 | 2004-10-20 | Novosis AG | Zeitgesteuert freisetzende wirkstoffhaltige transdermalsysteme |
| FR2793689B1 (fr) * | 1999-05-19 | 2001-08-24 | Pf Medicament | Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| EP1611882B1 (en) | 2004-06-01 | 2010-04-07 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
| SI1937276T1 (sl) | 2005-10-12 | 2013-04-30 | Unimed Pharmaceuticals, Llc C/O Abbott Laboratoires 100 Abbott Park Road | Izboljšani testosteronski gel in postopek uporabe |
| FR2895679B1 (fr) * | 2005-12-29 | 2012-06-08 | Pf Medicament | Stabilisation de testosterone au sein de dispositifs transdermiques |
| CN101480399B (zh) * | 2008-09-25 | 2011-10-05 | 宋博 | 睾酮在制备治疗弱精子症的药物中的应用 |
| DE102011012712A1 (de) | 2011-03-01 | 2012-09-06 | Frank Lehmann-Horn | Verwendung von Aldosteron-Rezeptor-Antagonisten zur Behandlung von weiblicher sexueller Dysfunktion |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4286592A (en) * | 1980-02-04 | 1981-09-01 | Alza Corporation | Therapeutic system for administering drugs to the skin |
| US4725439A (en) * | 1984-06-29 | 1988-02-16 | Alza Corporation | Transdermal drug delivery device |
| US4704282A (en) * | 1984-06-29 | 1987-11-03 | Alza Corporation | Transdermal therapeutic system having improved delivery characteristics |
| US4849224A (en) * | 1987-11-12 | 1989-07-18 | Theratech Inc. | Device for administering an active agent to the skin or mucosa |
| GB8804164D0 (en) * | 1988-02-23 | 1988-03-23 | Tucker J M | Bandage for administering physiologically active compound |
| US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| US5152997A (en) * | 1990-12-11 | 1992-10-06 | Theratech, Inc. | Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels |
| MX9202350A (es) * | 1991-05-20 | 1992-11-01 | Alza Corp | Composiciones de incrementador de penetracion a la piel que usan monolinoleato de glicerol. |
| CA2075517C (en) * | 1992-04-01 | 1997-03-11 | John Wick | Transdermal patch incorporating a polymer film incorporated with an active agent |
| AU677206B2 (en) * | 1992-06-11 | 1997-04-17 | Theratech, Inc. | The use of glycerin in moderating transdermal drug delivery |
| EP0695177B1 (de) * | 1993-04-20 | 1998-02-18 | Hexal Ag | Wirkstoffplaster |
| DE4313402A1 (de) * | 1993-04-23 | 1994-10-27 | Hexal Pharma Gmbh | Transdermale Wirkstoffzubereitung |
| US5460820B1 (en) * | 1993-08-03 | 1999-08-03 | Theratech Inc | Method for providing testosterone and optionally estrogen replacement therapy to women |
-
1995
- 1995-05-10 DE DE19517145A patent/DE19517145C2/de not_active Expired - Fee Related
-
1996
- 1996-05-10 SK SK1497-97A patent/SK149797A3/sk unknown
- 1996-05-10 DK DK96919765T patent/DK0825865T3/da active
- 1996-05-10 EP EP96919765A patent/EP0825865B1/de not_active Expired - Lifetime
- 1996-05-10 CN CN96193748A patent/CN1183723A/zh active Pending
- 1996-05-10 CA CA002220358A patent/CA2220358A1/en not_active Abandoned
- 1996-05-10 AT AT96919765T patent/ATE208200T1/de not_active IP Right Cessation
- 1996-05-10 HU HU9801130A patent/HUP9801130A3/hu unknown
- 1996-05-10 ZA ZA963743A patent/ZA963743B/xx unknown
- 1996-05-10 WO PCT/EP1996/002013 patent/WO1996035427A1/de active IP Right Grant
- 1996-05-10 JP JP8533786A patent/JPH11504643A/ja active Pending
- 1996-05-10 CZ CZ19973512A patent/CZ287678B6/cs not_active IP Right Cessation
- 1996-05-10 AU AU58050/96A patent/AU702710B2/en not_active Ceased
- 1996-05-10 BR BR9608255A patent/BR9608255A/pt not_active Application Discontinuation
- 1996-05-10 NZ NZ308516A patent/NZ308516A/xx unknown
- 1996-05-10 PL PL96323145A patent/PL323145A1/xx unknown
- 1996-05-10 DE DE59608150T patent/DE59608150D1/de not_active Expired - Fee Related
-
1997
- 1997-11-07 NO NO975140A patent/NO975140L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL323145A1 (en) | 1998-03-16 |
| CA2220358A1 (en) | 1996-11-14 |
| AU702710B2 (en) | 1999-03-04 |
| JPH11504643A (ja) | 1999-04-27 |
| SK149797A3 (en) | 1998-05-06 |
| AU5805096A (en) | 1996-11-29 |
| HUP9801130A3 (en) | 2001-03-28 |
| DE19517145C2 (de) | 2000-02-24 |
| NZ308516A (en) | 1999-05-28 |
| HUP9801130A2 (hu) | 1998-08-28 |
| CZ287678B6 (en) | 2001-01-17 |
| DK0825865T3 (da) | 2002-02-18 |
| EP0825865B1 (de) | 2001-11-07 |
| ATE208200T1 (de) | 2001-11-15 |
| EP0825865A1 (de) | 1998-03-04 |
| DE19517145C1 (de) | 1996-11-28 |
| DE59608150D1 (de) | 2001-12-13 |
| ZA963743B (en) | 1996-11-18 |
| NO975140D0 (no) | 1997-11-07 |
| CZ351297A3 (cs) | 1998-03-18 |
| CN1183723A (zh) | 1998-06-03 |
| BR9608255A (pt) | 1999-02-02 |
| WO1996035427A1 (de) | 1996-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO953874L (no) | Farmasöytisk preparat inneholdende lipofile legemidler | |
| PL324552A1 (en) | Plaster for pecutaneous administration of hormones | |
| NO975140L (no) | Transdermalt terapeutisk system (TTS) for administrasjon av testosteron | |
| YU49026B (sh) | UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE | |
| GB9611563D0 (en) | Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate | |
| PT1003490E (pt) | Sistema terapeutico transdermico (tts) para administracao de hormonas sexuais esteroides | |
| AU3909597A (en) | Dosage form for providing ascending dose of drug | |
| DE69327432D1 (de) | Heilmittel für wunden und hämorrhoiden | |
| NO942325D0 (no) | Transdermalt administrert system som inneholder acetylsalicylsyre for tromboseterapi og cancerprofylakse | |
| PT1003477E (pt) | Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel | |
| NO924723D0 (no) | Farmakologisk anvendelse av visse cystinderivater | |
| RU95105973A (ru) | Способ снижения тяжести токсоплазмоза, фармацевтическая композиция, применение производных рифамицина для получения лекарственных препаратов для лечения токсоплазмоза | |
| KR950028767A (ko) | 피부통과 투약을 위한 신규의 약제학적 투여 형태 | |
| AU1277792A (en) | Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts | |
| AU7291996A (en) | Transdermal therapeutic system (tts) for the administration of drugs for treatment of drug dependency or drug addiction | |
| CA2331414A1 (en) | Transdermal therapeutic system for the administration of candesartan | |
| DK681887A (da) | Azolderivat, fremgangsmaade til fresmtilling heraf samt landburgsmaessigt/havebrugsmaessigt fungicid indeholdende derivatet som aktiv bestanddel | |
| ATE296115T1 (de) | Ortsspezifische arzneimittel verabreichung | |
| NO952234L (no) | Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft | |
| NO953003L (no) | Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater | |
| MX9302986A (es) | Medicamento que contiene metrifonato y procedimiento para su preparacion | |
| HUP0104941A2 (hu) | Több gyógyszerformát tartalmazó bliszter | |
| ECSP972295A (es) | Metodos y composiciones para modular la respuesta sexual humana | |
| MX9705324A (es) | Sistema terapeutico transdermal para el suministro de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmaceuticamente aptas. | |
| AU4391196A (en) | A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |